Marine Institute and Department of Agriculture, Food and the Marine to co-fund food research

Posted On: April 3, 2013

The Department of Agriculture, Food and the Marine Institute (DAFM) has announced a call for marine research projects relating to Food Innovation, Food Processing Technologies and Food for Health. Researchers in higher education institutions and research institutions and on the island of Ireland are invited to submit proposals under the Food Industry Research Measure (FIRM) in an initiative jointly funded by the Department of Agriculture, Food and the Marine and the Marine Institute.

The recent announcement by DAFM for research proposals under the Food Industry Research Measure (FIRM) reflects the importance of maximizing Ireland’s potential to exploit the commercial potential of our natural resources. In a continuation of collaboration between DAFM and the Marine Institute to co-fund strategic research, this FIRM programme includes a dedicated call for marine origin foods research; seeking to build on the investment made by both parties to the marine functional foods research initiative – NutraMara.

More info

 

Chinese invest in Flinders University seaweed research

Posted On: March 21, 2013

Flinders University is to receive $450,000 over three years from a major Chinese corporation to further the University’s research into the potential conversion of seaweed into a range of high value products including foods, cosmetics and medicinal compounds.

Minister for Science and Information Economy Grace Portolesi today officially opened the world class marine biotechnology laboratory on seaweeds at Flinders University.

The research agreement between Flinders and the Gather Great Ocean Group (GGOG) of China was signed today at the opening ceremony. The Flinders University – GGOG Advanced Macroalgae Biotechnology Joint Laboratory initiative is a collaboration between the Flinders Centre for Marine Bioproducts Development, and GGOG, based in Qingdao, Shandong Province.

More info

 

Bluewave: Hydrolyzed fish protein set for US sports nutrition splash

Posted On: February 24, 2013

New sports nutrition product launches containing a new hydrolyzed fish protein are imminent, says Bluewave Marine Ingredients as it brings its branded AminoMarine ingredient to market.

More info

Canadian phytoplankton company signs Asia deal

Posted On: January 15, 2013

A Nanaimo-based company specializing in the health benefits of marine phytoplankton hopes a deal signed Saturday with a large Chinese health and marketing firm will pay big dividends.

After more than a decade of research and development, Canada Marine Biotech Research Corporation has formed a partnership with Nanjing-based Joy-main Science and Technology Development Comp. to launch a new health product in China using phytoplankton grown at CMBRC’s seaside location in Cedar.

The unique phytoplankton, which are microscopic marine plant-like organisms, are to be used in Joymain’s new “Cellight” products, intended to boost people’s energy levels, improve immune systems and enhance “general well being” in its users.

More info

 

Fish bones’ second life

Posted On: January 15, 2013

A new project is exploring means of turning fish waste into value-added products such as neutraceuticals while attempting to make fisheries a greener industry in developing countries.

Only about 50% of every fish sold as fillet is actually eaten.  Often, fish heads, viscera, skin and bones are discarded. In this context, the SECUREFISH project, funded by the EU, aims at reducing the post-harvest waste in the fisheries sector while improving the overall environmental friendliness of fish processing in developing countries. “We use the waste products that include fish skin and bones and process the proteins through hydrolysis into bioactive peptides,” explains project co-ordinator Nazlin Howell, Professor of Food Biochemistry, University of Surrey, Guilford, UK.

Scientists have discovered that some of the bioactive peptides isolated from fish waste exhibit an activity akin to that of a class of blood pressure lowering drugs called ACE inhibitors. Others also exhibit antioxidant properties and might reduce reactive oxygen species in cells. Such activity could have implications for cardiovascular disease and cancer prevention. Howell tells youris.com “[these] could be put into [food] products such as yoghurt and milk drinks” due to their potential health benefits.

More info

 

Company to convert seafood waste into products

Posted On: December 4, 2012

A company that plans to convert seafood waste into a range of commercial products will move into an empty bottling plant in Opelousas, creating 50 new jobs over five years.

AgraTech International said Wednesday it will spend $10 million to renovate the old Yoo-Hoo plant. The company will process shrimp, crawfish and crab shells to get chitosan, which is used in everything from water-repellant glass coatings to sunscreen lotion and from dental membranes to nasal sprays to treat nosebleeds.

The new jobs will pay an average annual salary of $50,000, plus benefits. Louisiana’s economic development department estimates 51 new indirect jobs will also be created.

More info

 

BC Marine Phytoplankton Attracts Chinese High Tech Healthcare Producer

Posted On: December 4, 2012

Canada Marine Biotech Research Corp. to host a December 15, 2012 luncheon event to welcome Nanjing Joymain Science and Technology Development Co. Ltd. The event will celebrate the strategic alliance formed between the British Columbia, Canadian company and Joymain, headquartered in Nanjing, China. Joymain is a high-tech R&D, production, and marketing company, a leader in health care products and commodities.

Joymain is introducing the launch of its “Cellight” line, which integrates the marine phytoplankton provided exclusively by Canada Marine Biotech of British Columbia. Chinese import certification has now been secured.

More info

Read more: http://www.digitaljournal.com/pr/957310#ixzz2E68A3NPM

 

Marine bioprospecting – a role for bioresource centers in the 21st century

Posted On: November 19, 2012

Marine bioprospecting – a role for bioresource centers in the 21st century. A presentation by Dr Willie Wilson (Director of National Center for Marine Algae and Microbiota, Bigelow Laboratory for Ocean Sciences, USA) presentation at the Oceans of Potential conference, Tuesday 11th September, Plymouth, UK

More info

Marine biotechnology advances towards applications in new functional foods

Posted On: November 19, 2012

The marine ecosystem is still an untapped reservoir of biologically active compounds, which have considerable potential to supply food ingredients towards development of new functional foods. With the goal of increasing the availability and chemical diversity of functional marine ingredients, much research has been developed using biotechnological tools to discover and produce new compounds.

This review summarizes the advances in biotechnological tools for production of functional ingredients, including enzymes, for the food industry. Tools involving biotechnological processes (bioreactors, fermentations, bioprocessing) and those involving genetic research designated as molecular biotechnology are discussed highlighting how they can be used in the controlled manipulation and utilization of marine organisms as sources of food ingredients, as well as discussing the most relevant shortcomings towards applications in new functional foods.

More info

Cyanotech Reports Financial Results

Posted On: November 17, 2012

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, including BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®, has announced financial results for the second quarter and first six months of fiscal year 2013, ended September 30, 2012.

Second Quarter 2013

For the second quarter of fiscal 2013 compared to the second quarter of fiscal 2012, revenues were $6,936,000 compared to $5,989,000, an increase of 16%. Gross profit was $2,812,000, with gross profit margin of 40.5%, compared to gross profit of $2,790,000 and gross profit margin of 46.6%. Net income was $476,000 or $0.08 per diluted share, compared to net income of $875,000 or $0.16 per diluted share.

More info

 
Follow Me on Twitter